Gottlieb Floats New Antibiotic Payment Model In LPAD Announcement
US FDA Commissioner outlines licensing fee reimbursement arrangement intended to provide better financial incentives for development.
US FDA Commissioner outlines licensing fee reimbursement arrangement intended to provide better financial incentives for development.